Iron in chronic brain disorders: imaging and neurotherapeutic implications
- PMID: 17599703
- PMCID: PMC1963417
- DOI: 10.1016/j.nurt.2007.05.006
Iron in chronic brain disorders: imaging and neurotherapeutic implications
Abstract
Iron is important for brain oxygen transport, electron transfer, neurotransmitter synthesis, and myelin production. Though iron deposition has been observed in the brain with normal aging, increased iron has also been shown in many chronic neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In vitro studies have demonstrated that excessive iron can lead to free radical production, which can promote neurotoxicity. However, the link between observed iron deposition and pathological processes underlying various diseases of the brain is not well understood. It is not known whether excessive in vivo iron directly contributes to tissue damage or is solely an epiphenomenon. In this article, we focus on the imaging of brain iron and the underlying physiology and metabolism relating to iron deposition. We conclude with a discussion of the potential implications of iron-related toxicity to neurotherapeutic development.
Similar articles
-
Role of iron in neurotoxicity: a cause for concern in the elderly?Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):22-9. doi: 10.1097/MCO.0b013e32831ba07c. Curr Opin Clin Nutr Metab Care. 2009. PMID: 19057183 Review.
-
Brain iron accumulation in aging and neurodegenerative disorders.Expert Rev Neurother. 2012 Dec;12(12):1467-80. doi: 10.1586/ern.12.128. Expert Rev Neurother. 2012. PMID: 23237353 Review.
-
Magnetic resonance imaging of iron deposition in neurological disorders.Top Magn Reson Imaging. 2006 Feb;17(1):31-40. doi: 10.1097/01.rmr.0000245459.82782.e4. Top Magn Reson Imaging. 2006. PMID: 17179895 Review.
-
Iron and neurodegenerative disorders.Brain Res Bull. 2001 May 15;55(2):155-64. doi: 10.1016/s0361-9230(01)00510-x. Brain Res Bull. 2001. PMID: 11470311 Review.
-
Role of iron in brain development, aging, and neurodegenerative diseases.Ann Med. 2025 Dec;57(1):2472871. doi: 10.1080/07853890.2025.2472871. Epub 2025 Mar 4. Ann Med. 2025. PMID: 40038870 Free PMC article. Review.
Cited by
-
Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration.Biomed Spectrosc Imaging. 2013 Apr 1;2(2):129-139. doi: 10.3233/BSI-130041. Biomed Spectrosc Imaging. 2013. PMID: 24926425 Free PMC article.
-
Migraine and Risk of Parkinson Disease in Women: A Cohort Study.Neurology. 2024 Sep 24;103(6):e209747. doi: 10.1212/WNL.0000000000209747. Epub 2024 Aug 21. Neurology. 2024. PMID: 39167748 Clinical Trial.
-
The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease.Front Neurosci. 2018 Dec 20;12:981. doi: 10.3389/fnins.2018.00981. eCollection 2018. Front Neurosci. 2018. PMID: 30618597 Free PMC article. Review.
-
Kinetics of iron import into developing mouse organs determined by a pup-swapping method.J Biol Chem. 2015 Jan 2;290(1):520-8. doi: 10.1074/jbc.M114.606731. Epub 2014 Nov 4. J Biol Chem. 2015. PMID: 25371212 Free PMC article.
-
Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron.Circ Res. 2016 Nov 11;119(11):1164-1166. doi: 10.1161/CIRCRESAHA.116.309746. Circ Res. 2016. PMID: 28051781 Free PMC article. Review.
References
-
- Gutteridge JM. Iron and oxygen radicals in brain. Ann Neurol. 1992;32:S16–S21. - PubMed
-
- Pujol J, Juque C, Vendrell P, et al. Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol. 1992;49:711–717. - PubMed
-
- Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989;52:515–520. - PubMed
-
- Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in post-mortem parkinsonian brain. Lancet. 1987;341:1219–1220. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical